International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study

Baylor College of Medicine, Houston, Texas, United States
Movement Disorders (Impact Factor: 5.68). 07/2006; 21(7):916-23. DOI: 10.1002/mds.20844
Source: PubMed


Nonmotor symptoms (NMS) of Parkinson's disease (PD) are not well recognized in clinical practice, either in primary or in secondary care, and are frequently missed during routine consultations. There is no single instrument (questionnaire or scale) that enables a comprehensive assessment of the range of NMS in PD both for the identification of problems and for the measurement of outcome. Against this background, a multidisciplinary group of experts, including patient group representatives, has developed an NMS screening questionnaire comprising 30 items. This instrument does not provide an overall score of disability and is not a graded or rating instrument. Instead, it is a screening tool designed to draw attention to the presence of NMS and initiate further investigation. In this article, we present the results from an international pilot study assessing feasibility, validity, and acceptability of a nonmotor questionnaire (NMSQuest). Data from 123 PD patients and 96 controls were analyzed. NMS were highly significantly more prevalent in PD compared to controls (PD NMS, median = 9.0, mean = 9.5 vs. control NMS, median = 5.5, mean = 4.0; Mann-Whitney, Kruskal-Wallis, and t test, P < 0.0001), with PD patients reporting at least 10 different NMS on average per patient. In PD, NMS were highly significantly more prevalent across all disease stages and the number of symptoms correlated significantly with advancing disease and duration of disease. Furthermore, frequently, problems such as diplopia, dribbling, apathy, blues, taste and smell problems were never previously disclosed to the health professionals.

Download full-text


Available from: Kallol Ray Chaudhuri
  • Source
    • "Each question is answered with " yes " or " no " . One point is scored for each positive response ( " yes " ) resulting in a score ranging from 0 to 30 [9] [24]. 2.7.3. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hypomimia which refers to a reduced degree in facial expressiveness is a common sign in Parkinson's disease (PD). The objective of our study was to investigate how hypomimia affects PD patients' facial expression of pain. The facial expressions of 23 idiopathic PD patients in the Off-phase (without dopaminergic medication) and Onphase (after dopaminergic medication intake) and 23 matched controls in response to phasic heat-pain and a temporal summation procedure were recorded and analyzed for overall and specific alterations using the Facial Action Coding System (FACS). We found reduced overall facial activity in response to pain in PD patients in the Off which was less pronounced in the On. Especially the highly pain-relevant eye-narrowing occurred less frequently in PD patients than in controls in both phases while frequencies of other pain-relevant movements, like upper lip raise (in the On) and contraction of the eyebrows (in both phases), did not differ between groups. Moreover, opening of the mouth (which is often not considered as pain-relevant) was the most frequently displayed movement in PD patients, whereas eye-narrowing was the most frequent movement in controls. Not only overall quantitative changes in the degree of facial pain expressiveness occurred in PD patients but also qualitative changes were found. The latter refer to a strongly affected encoding of the sensory dimension of pain (eye-narrowing) while the encoding of the affective dimension of pain (contradiction of the eyebrows) was preserved. This imbalanced pain signal might affect pain communication and pain assessment.
    Full-text · Article · Nov 2015 · Journal of the Neurological Sciences
  • Source
    • "Parkinson's disease (PD) is a chronic progressive neurodegenerative disorder characterized by motor symptoms such as tremor at rest, rigidity, bradykinesia and postural instability [1]. Patients with PD may develop various non-motor symptoms such as psychosis , cognitive dysfunction, depression, sleep disturbances and autonomic dysfunctions during the course of the illness [2]. Psychosis is one of the common and debilitating non-motor symptoms of PD and visual hallucinations (VH) are the commonest manifestation of psychosis in PD [3]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Patients with Parkinson's disease may develop various non-motor symptoms during the course of the illness. Visual hallucinations (VH) and cognitive impairment (CI) are two common non-motor symptoms of Parkinson's disease. Studies have reported association of both VH and CI with presence of rapid eye movement sleep behavior disorder (RBD). Presence of visual hallucinations and cognitive impairment has been described as risk factors for emergence of each other. There is marked overlap in the risk factors for development of RBD, VH and CI in patients with PD. Results of clinical and epidemiological studies as well as studies based on neuroimaging, electrophysiology especially transcranial magnetic stimulation and neuropsycholgical evaluations in PD patients have suggested presence of certain common neurobiological process leading to emergence of RBD, VH and CI. Structural neuroimaging studies using voxel-based morphometry have often reported grey matter atrophy of hippocampus and parahippocampal cortices in PD patients with RBD, VH and CI. Cholinergic dysfunction is common in PD patients with RBD, VH and CI. This review explores the complex interactions of RBD, VH and CI in patients with PD and their potential implications.
    Full-text · Article · Nov 2015 · Parkinsonism & Related Disorders
  • Source
    • "Two dichotomous items on anxiety and orthostatism (no. 17 and 20) of the Nonmotor Symptoms Questionnaire (NMSQuest) [36] were also included. In addition, the Geriatric Depression Scale (GDS-15) [37] was administered as an interview. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Fear of falling can be conceptualized in different ways, e.g., as concerns about falling or low fall-related self-efficacy. It is common in people with Parkinson's disease (PD), and there is growing knowledge about its contributing factors. However, previous multivariate studies have mainly focused on fear of falling in relation to PD-related disabilities, and less is known about the associations between fear of falling and personal and environmental factors. To identify explanatory factors of concerns about falling in people with PD by focusing on personal and environmental factors as well as PD-related disabilities. Data were collected from 241 persons with PD (39% women, median age 70 years, PD duration 8 years). Concerns about falling (assessed with the Falls Efficacy Scale-International, FES-I; categorized into low, moderate, or high concerns) were used as the dependent variable in a multivariate ordinal regression analysis. Personal factors, environmental factors and PD-related disabilities constituted independent variables. Low, moderate and high concerns about falling were reported by 29%, 24% and 47% of the participants, respectively. Walking difficulties, orthostatism, motor symptoms, age, and fatigue (presented in order of importance) were significant (p < 0.05) explanatory factors of concerns about falling. Several factors significantly explained concerns about falling in people with PD. Walking difficulties was by far the strongest explanatory factor. This suggests that minimizing walking difficulties should be a primary target when aiming at reducing concerns about falling in people with PD.
    Full-text · Article · Apr 2015
Show more